NYSE: ABT
Abbott Laboratories Earnings & Revenue

ABT past earnings growth

How has ABT's earnings growth performed historically?
Company
113.68%
Industry
94.53%
Market
91.39%
ABT's earnings have grown faster... subscribe to Premium to read more.
Performance
ABT's earnings have grown faster... subscribe to Premium to read more.
Performance
ABT's earnings growth is accelerating... subscribe to Premium to read more.
Performance

ABT past revenue growth

How has ABT's revenue growth performed historically?
Company
31.31%
Industry
25.58%
Market
42.01%
ABT's revenue has grown slower... subscribe to Premium to read more.
Performance
ABT's revenue has grown slower... subscribe to Premium to read more.
Performance
ABT's revenue growth is accelerating... subscribe to Premium to read more.
Performance

ABT earnings and revenue history

Current Revenue
$42.3B
Current Earnings
$7.2B
Current Profit Margin
17.1%
ABT's has not demonstrated consistent... subscribe to Premium to read more.
Performance

ABT Return on equity

Current Company
21.4%
Current Industry
3.7%
Current Market
93.9%
ABT's Return on Equity (21.4%)... subscribe to Premium to read more.
Performance

ABT Return on assets

Current Company
9.9%
Current Industry
6.2%
ABT is generating higher Return... subscribe to Premium to read more.
Performance

ABT Return on capital employed

Current Company
14.47%
Current Industry
9.9%
ABT has gotten more efficient... subscribe to Premium to read more.
Performance

Abbott Laboratories Earnings & Revenue FAQ

What were ABT's earnings last quarter?

On Invalid Date, Abbott Laboratories (NYSE: ABT) reported Q3 2021 earnings per share (EPS) of $1.18, up 71.01% year over year. Total Abbott Laboratories earnings for the quarter were $2.10 billion. In the same quarter last year, Abbott Laboratories's earnings per share (EPS) was $0.69.

What was ABT's earnings growth in the past year?

As of Q1 2022, Abbott Laboratories's earnings has grown 113.68% year over year. This is 19.16 percentage points higher than the US Medical Devices industry earnings growth rate of 94.53%. Abbott Laboratories's earnings in the past year totalled $7.24 billion.

What was ABT's revenue last quarter?

On Invalid Date, Abbott Laboratories (NYSE: ABT) reported Q3 2021 revenue of $10.93 billion up 23.44% year over year. In the same quarter last year, Abbott Laboratories's revenue was $8.85 billion.

What was ABT's revenue growth in the past year?

As of Q1 2022, Abbott Laboratories's revenue has grown 31.31% year over year. This is 5.73 percentage points higher than the US Medical Devices industry revenue growth rate of 25.58%. Abbott Laboratories's revenue in the past year totalled $42.31 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.